Bladder Cancer - Results from #300

REVIEW UroToday

Evaluating Antibody-Drug Conjugates Combination with Radiation Therapy in Bladder Cancer - Expert Commentary June 20, 2024

Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis. June 20, 2024

Digital spatial profiling of the microenvironment of muscle invasive bladder cancer. June 20, 2024

NON-ALCOHOLIC FATTY LIVER DISEASE AND EXTRA-HEPATIC CANCER: A NARRATIVE REVIEW. June 20, 2024

Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer. June 20, 2024

Enfortumab vedotin and pembrolizumab combination as a relevant game changer in urothelial carcinoma: What is left behind? June 19, 2024

On the Road Towards Curing Advanced Bladder Cancer. June 19, 2024

Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program. June 19, 2024

Beyond the Buzzwords: How AI and Advancing Diagnostic Technologies Will Transform Early Bladder Cancer Care June 18, 2024

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience. June 18, 2024

Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer. June 18, 2024

What About Variant Histologies in Bladder Cancer? June 17, 2024

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion. June 17, 2024

Multidisciplinary management of sexual and gender minorities with bladder cancer. June 17, 2024

Valar Labs Announces Validation of First Histology-based Test to Predict Response to BCG in Bladder Cancer June 14, 2024

Valar Labs Announces $22 Million Series A to Advance Vesta, First AI Diagnostic Test to Predict Treatment Response in Bladder Cancer, and Catalyze Expansion in Other Cancers June 14, 2024

Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates. June 14, 2024

Prognostic significance of EGFR, AREG and EREG amplification and gene expression in muscle invasive bladder cancer. June 14, 2024

UroGen Surges on Updated Late-Stage Data for Bladder Cancer Therapy June 13, 2024

A Tool for Evaluating Artificial Intelligence Studies for Predicting NMIBC Outcomes - Expert Commentary June 13, 2024

Page 16 of 517